Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-24 Purchase | 2023-03-24 8:54 pm | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 10,000 | $4.314 | $43,140 | 22,010 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-30 Exercise | 2024-02-01 6:00 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 9,275 | $0 | 72,837 (Direct) | View |
| 2024-01-30 Tax Withholding | 2024-02-01 6:00 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 2,175 | $9.8 | 72,837 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-01 6:00 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 4,621 | $2.69 | 72,837 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-29 6:30 pm | N/A 2034-01-25 | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 221,600 | $0 | 221,600 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-02 6:00 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 12,500 | $0 | 58,291 (Direct) | View |
| 2023-12-29 Tax Withholding | 2024-01-02 6:00 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 3,044 | $11.25 | 58,291 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 5:51 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 1,825 | $2.81 | 23,835 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:09 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 1,172 | $10.21 | 12,010 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 5:31 pm | N/A 2033-01-30 | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 142,100 | $0 | 142,100 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-03 5:59 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 12,500 | $0 | 48,338 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-03 5:59 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 3,028 | $16.45 | 48,338 (Direct) | View |
| 2022-07-31 Option Award | 2022-08-03 4:05 pm | N/A N/A | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 1,366 | $6.86 | 1,366 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 06:11 am | N/A 2031-12-31 | Altimmune Inc. | ALT | Eisenstadt Richard I Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-05 7:15 pm | N/A N/A | AYTU BIOPHARMA INC | AYTU | Eisenstadt Richard I Chief Financial Officer | 55,000 | $0 | 68,734 (Direct) | View |
Ownership | 2021-04-05 7:14 pm | N/A N/A | AYTU BIOPHARMA INC | AYTU | Eisenstadt Richard I Chief Financial Officer | 0 | $0 | 13,734 (Direct) | View |
| 2021-03-19 Disposition | 2021-03-19 5:04 pm | N/A N/A | Neos Therapeutics Inc. | NEOS | Eisenstadt Richard I Chief Financial Officer | 781,668 | $0 | 0 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-16 08:49 am | N/A N/A | Neos Therapeutics Inc. | NEOS | Eisenstadt Richard I Chief Financial Officer | 1,390 | $0.883 | 126,245 (Direct) | View |
| 2021-03-02 Tax Withholding | 2021-03-16 08:49 am | N/A N/A | Neos Therapeutics Inc. | NEOS | Eisenstadt Richard I Chief Financial Officer | 14,825 | $0.844 | 126,245 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 5:22 pm | N/A 2030-03-02 | Neos Therapeutics Inc. | NEOS | Eisenstadt Richard I Chief Financial Officer | 215,000 | $0 | 257,460 (Direct) | View |